InvestorsHub Logo

DonShimoda

03/22/12 12:10 PM

#17503 RE: JJM760 #17501

Thanks. Considering Roche and Pfizer are actively pursuing endometrial combo trials, I wonder if it has more to do with the lack of a PI3K inhibitor in MRK's pipeline.